18th Dec 2019 16:29
(Alliance News) - Scancell Holdings PLC said Tuesday that an investment vehicle of Non-Executive Director Martin Diggle bought 2.9 million shares on Monday.
Vulpes Life Science Fund paid 5.2 pence per share in a single transaction, making the deal worth GBP152,100. Diggle's Vuples now holds at 17.3% stake in Scancell, which is develops immunotherapies for the treatment of cancer.
Scancell shares were down 0.5% late Wednesday at 5.22p.
By Tom Waite; [email protected]
Copyright 2019 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings